A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9 | Zendy

Jeroen Goos | Zendy; Veerle M.H. Coupé | Zendy; Mark A. van de Wiel | Zendy; Begoña Diosdado | Zendy; Pien M. Delisvan Diemen | Zendy; Annemieke C. Hiemstra | Zendy; Erienne M.V. de Cuba | Zendy; Jeroen A.M. Beliën | Zendy; C. Willemien Menkevan der Houven van Oordt | Zendy; Albert A. Geldof | Zendy; Gerrit A. Meijer | Zendy; Otto S. Hoekstra | Zendy; Remond J.A. Fijneman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9

Author(s) -

Jeroen Goos,

Veerle M.H. Coupé,

Mark A. van de Wiel,

Begoña Diosdado,

Pien M. Delisvan Diemen,

Annemieke C. Hiemstra,

Erienne M.V. de Cuba,

Jeroen A.M. Beliën,

C. Willemien Menkevan der Houven van Oordt,

Albert A. Geldof,

Gerrit A. Meijer,

Otto S. Hoekstra,

Remond J.A. Fijneman

Publication year - 2015

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.6188

Subject(s) - medicine , colorectal cancer , metastasis , mmp9 , oncology , cancer , cancer research , biology , downregulation and upregulation , gene , biochemistry

Prognosis of patients with colorectal cancer liver metastasis (CRCLM) is estimated based on clinicopathological models. Stratifying patients based on tumor biology may have additional value.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research